Table 4. Factors associated with improvement rate of pneumonitis.
Variable | Univariate analysis | Multivariable analysis | |||
---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | ||
Age ≥65 years | 3.00 (0.71–12.74) | 0.131 | 1.75 (0.30–10.20) | 0.533 | |
Male vs. female | 0.69 (0.13–3.73) | 0.666 | 2.43 (0.20–29.69) | 0.487 | |
Smoker | 0.58 (0.16–2.16) | 0.420 | 0.29 (0.04–3.21) | 0.291 | |
Grade 3–5 CIP | 0.16 (0.04–0.69) | 0.014 | 0.17 (0.03–0.92) | 0.039 | |
Radiotherapy at baseline | 0.53 (0.11–2.54) | 0.427 | 0.37(0.04–3.21) | 0.367 | |
ICI treatment ≥2nd line | 0.25 (0.03–0.99) | 0.048 | 0.40 (0.08–2.06) | 0.272 | |
Histology (squamous vs. nonsquamous) | 1.48 (0.38–5.73) | 0.572 | 3.17 (0.51–19.65) | 0.214 |
ICI, immune checkpoint inhibitor; CIP, immune checkpoint inhibitor-related pneumonitis; OR, odds ratio; CI, confidence interval.